Ganaxolone Shows Potential in Treating CDKL5 and Reveals Biomarker in PCDH19 Epilepsy
stevepb / Pixabay

Ganaxolone Shows Potential in Treating CDKL5 and Reveals Biomarker in PCDH19 Epilepsy

According to a story from globenewswire.com, the biopharmaceutical company Marinus Pharmaceuticals, Inc., recently announced the presentation of Phase 2 clinical trial of the drug ganaxolone as a treatment for CDKL5…

Continue Reading Ganaxolone Shows Potential in Treating CDKL5 and Reveals Biomarker in PCDH19 Epilepsy
PKU and Living Medicines: Spotlight Synlogic  
https://pixabay.com/en/seattle-washington-city-state-3465797/

PKU and Living Medicines: Spotlight Synlogic  

Press releases earlier this year on biotech company, Synlogic, announced quite favorable results on both pre-clinical and clinical data on a unique application of synthetic biology for the rare disease, phenylketonuria (PKU). In just…

Continue Reading PKU and Living Medicines: Spotlight Synlogic  
“Many Faces of NF”: Artist Highlights Tumor-Causing Genetic Disorder
mcmurryjulie / Pixabay

“Many Faces of NF”: Artist Highlights Tumor-Causing Genetic Disorder

If you haven't heard of neurofibromatosis (NF), you’re in surprisingly good company. For most of her life, Rachel Mindrup, an artist, illustrator, and Resident Assistant Professor at Creighton University, who…

Continue Reading “Many Faces of NF”: Artist Highlights Tumor-Causing Genetic Disorder
The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy
Source: Pixabay.com

The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy

This past Sunday, December 2nd, during the Patriot's game against the Minnesota Vikings, 20 players wore customized cleats to spread awareness for various philanthropic causes. This is the third year…

Continue Reading The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy